We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
+17.46%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$1.94B
AUM Growth
+$209M
Cap. Flow
+$157M
Cap. Flow %
8.08%
Top 10 Hldgs %
37.79%
Holding
268
New
72
Increased
34
Reduced
55
Closed
76

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$16.3M
2
SONX
Sonendo, Inc.
SONX
+$7.34M
3
NTRA icon
Natera
NTRA
+$6.8M
4
AZTA icon
Azenta
AZTA
+$6.45M
5
QTRX icon
Quanterix
QTRX
+$5.89M

Top Sells

Rank Stock Value
1
UTHR icon
United Therapeutics
UTHR
+$22.4M
2
ILMN icon
Illumina
ILMN
+$11.7M
3
AZN icon
AstraZeneca
AZN
+$9.6M
4
OM icon
Outset Medical
OM
+$8.46M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$7.3M

Sector Composition

Rank Sector Weight
1 Healthcare 27.35%
2 Industrials 0.25%
3 Materials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NGM
251
PUT
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
– –
-60,000
Closed -$785K
SNCE
252
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
– –
-55,320
Closed -$1.78M
MRTX
253
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
– –
-20,000
Closed -$1.29M
SLGC
254
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
– –
-2,213,200
Closed -$6.42M
ICPT
255
CALL
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
– –
-200,000
Closed -$2.79M
RETA
256
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
– –
-55,596
Closed -$1.4M
AMRS
257
DELISTED
Amyris Inc.
AMRS
– –
-875,000
Closed -$2.56M
AMRS
258
PUT
DELISTED
Amyris Inc.
AMRS
– –
-700,000
Closed -$2.04M
JNCE
259
CALL
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
– –
-182,200
Closed -$426K
OSH
260
PUT
DELISTED
Oak Street Health, Inc.
OSH
– –
-100,000
Closed -$2.45M
PRVB
261
CALL
DELISTED
Provention Bio, Inc. Common Stock
PRVB
– –
-56,100
Closed -$252K
APEN
262
DELISTED
Apollo Endosurgery, Inc.
APEN
– –
-427,057
Closed -$2.35M
RCOR.WS
263
DELISTED
Renovacor, Inc. Warrants, entitling the holder thereof to purchase one-half (1/2) of a share of common stock at a price of $11. 50 per whole share
RCOR.WS
– –
-150,632
Closed -$12K
RCOR
264
DELISTED
Renovacor, Inc.
RCOR
– –
-59,352
Closed -$150K
QTNT
265
DELISTED
Quotient Limited Ordinary Shares
QTNT
– –
-153,162
Closed -$919K
7 8 9 10
11

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q4 2022 Portfolio in Review

As of Q4 2022, Pura Vida Investments held 268 positions worth $1.94B, up 12% from $1.73B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Pura Vida Investments deployed $157M of net new capital in Q4 2022, opening 72 new positions and adding to 34 existing holdings. Its largest new stake was Natera: 165,000 shares worth $6.63M.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 35% a quarter earlier, followed by Industrials and Materials.

On the sell side, the largest reduction was United Therapeutics, an estimated $22.4M trimmed.

  • Pura Vida Investments's largest Q4 2022 buy was Natera: 165,000 shares worth $6.63M.
  • Pura Vida Investments added most to Biogen in Q4 2022, an estimated $16.3M increase.
  • Pura Vida Investments's biggest Q4 2022 reduction was United Therapeutics, cutting an estimated $22.4M.
  • Pura Vida Investments fully exited Illumina in Q4 2022, selling an estimated $11.7M.
  • Pura Vida Investments's ten largest holdings make up 38% of its $1.94B portfolio in Q4 2022.
  • Pura Vida Investments opened 72 new positions and closed 76 in Q4 2022.
  • Pura Vida Investments's portfolio value rose 12% quarter-over-quarter to $1.94B.

Based on Pura Vida Investments's 13F filing for Q4 2022, filed 14 Feb 2023.